We are live on ! Find out more
NVAX icon

Novavax

186 hedge funds and large institutions have $1.59B invested in Novavax in 2016 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

52% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 21

40% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 47

39% more capital invested

Capital invested by funds: $1.15B → $1.59B (+$445M)

6% more funds holding

Funds holding: 175186 (+11)

57% less call options, than puts

Call options by funds: $15.6M | Put options by funds: $36M

Holders
186
Holders Change
+11
Holders Change %
+6.29%
% of All Funds
4.96%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
32
Increased
66
Reduced
47
Closed
21
Calls
$15.6M
Puts
$36M
Net Calls
-$20.4M
Net Calls Change
-$18.5M

NVAX Hedge Fund Activity: Q2 2016 in Review

186 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2016, worth a combined $1.59B — up 39% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NVAX positions and 21 closed out — a net gain of 11 holders — while 66 added to existing stakes and 47 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $12.2M. The largest seller was State Street, cutting an estimated $18.9M.

  • 186 institutional investors held Novavax (NVAX) as of Q2 2016, up from 175 in Q1 2016.
  • Funds reported $1.59B of Novavax stock for Q2 2016, up 39% quarter-over-quarter.
  • 32 funds opened new Novavax positions in Q2 2016 and 21 closed out, a net change of +11 holders.
  • The largest Novavax buyer in Q2 2016 was Janus Henderson Investors US, an estimated $12.2M added.
  • The largest Novavax seller in Q2 2016 was State Street, an estimated $18.9M sold.

Based on aggregated 13F filings for Q2 2016.